stars 1 stars 2 stars 3

VERDOT, established in 1950 and headquartered in Riom, France, stands at the forefront of downstream bioprocessing technology. VERDOT provides innovative single-use and stainless steel purification solutions for the biopharmaceutical industry, including chromatography columns and skids as well as tangential flow filtration (TFF) systems. Ranging from standard to highly customized designs, VERDOT systems and columns are employed in the purification, separation and concentration of biomolecules such as monoclonal antibodies, vaccines, viral vectors (e.g., AAV and lentivirus), and mRNA-based therapeutics. VERDOT serves a diverse customer base, including research and development, early-stage biotech, biopharma, and contract development and manufacturing organizations (CDMOs) in all stages of the drug development workflow from exploration through the manufacturing of commercially available biologics. VERDOT’s tailored, high-quality purification technologies empower their customers to accelerate time-to-market of groundbreaking and cost-effective therapies. For more information about VERDOT, visit www.verdot-biotechnologies.com

VERDOT Questions

The VERDOT annual revenue was $23.5 million in 2026.

Charles Ruban is the CEO of VERDOT.

48 people are employed at VERDOT.

Top VERDOT Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users